Elizabeth Plimack tells us why the avelumab switch maintenance strategy trialled in JAVELIN Bladder 100 could be a game changer for the field of advanced urothelial cancer (3:51).
03-06-2020 | ASCO 2020 | Conference coverage | Video
03-06-2020 | ASCO 2020 | Conference coverage | Video
Elizabeth Plimack tells us why the avelumab switch maintenance strategy trialled in JAVELIN Bladder 100 could be a game changer for the field of advanced urothelial cancer (3:51).